High court asked to block morning-after pill rule

by Tim Talley

(AP)—Hobby Lobby Stores is asking the U.S. Supreme Court to block part of the federal health care law that requires it to provide insurance coverage for the morning-after pill and similar emergency contraception pills.

The arts-and-crafts company is owned by a conservative Christian family. They argue the drugs are tantamount to abortion because they can prevent a fertilized egg from implanting in a woman's womb.

Oklahoma-based Hobby Lobby asked the high court for an injunction Friday, a day after a rejected the company's request. A U.S. District judge turned down the company last month.

Hobby Lobby is the largest private employer suing over the mandate. Not providing the drugs will subject the company to fines of as much as $1.3 million a day.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Hobby Lobby asks judge to block health care law

Nov 01, 2012

(AP)—An arts and craft supply company says part of the new federal health care law should be blocked because it requires coverage for morning-after and week-after birth control pills.

US appeals court upholds Obama's health care law

Jun 29, 2011

A US federal appeals court in Ohio upheld the constitutionality of President Barack Obama's controversial health care law Wednesday in the first rejection of several challenges at the appeals court level.

Court Denies Vonage Bid for Patent Case Retrial

May 04, 2007

A U.S. appeals court denies a request by Internet phone company Vonage Holdings that it order a retrial in the patent infringement case brought against it by Verizon Communications.

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

kochevnik
2.3 / 5 (3) Dec 21, 2012
Christopaths should move to Iran